Showing 1,821 - 1,840 results of 8,891 for search 'significant ((((step decrease) OR (((we decrease) OR (teer decrease))))) OR (mean decrease))', query time: 0.58s Refine Results
  1. 1821

    Primer sequences. by Ceyan Kuang (8554557)

    Published 2025
    “…Microinjection of HL-IR double-stranded RNA (dsRNA) showed that reduced transcript levels led to significant decreases in the tick repellency rate from cinnamaldehyde and the EAG response of Haller’s organ. …”
  2. 1822
  3. 1823
  4. 1824

    All measurement data obtained for this study. by Brendan M. Anderson (11234356)

    Published 2024
    “…One clade increased in size, one decreased, and another exhibited no substantial change. …”
  5. 1825

    Regional stratigraphic correlation. by Brendan M. Anderson (11234356)

    Published 2024
    “…One clade increased in size, one decreased, and another exhibited no substantial change. …”
  6. 1826
  7. 1827

    Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

    Published 2025
    “…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. Decreasing lipophilicity led to the discovery of <b>NP3-742</b>, demonstrating a favorable overall profile including diminished hERG inhibition and in vivo efficacy in a mouse peritonitis model.…”
  8. 1828

    Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

    Published 2025
    “…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. Decreasing lipophilicity led to the discovery of <b>NP3-742</b>, demonstrating a favorable overall profile including diminished hERG inhibition and in vivo efficacy in a mouse peritonitis model.…”
  9. 1829

    Discovery of NP3-742: A Structurally Diverse NLRP3 Inhibitor Identified through an Unusual Phenol Replacement by Juraj Velcicky (2201350)

    Published 2025
    “…Initial indole analog <b>7</b> demonstrated a robust in vivo IL-1β inhibition, but also a significant hERG inhibition. Decreasing lipophilicity led to the discovery of <b>NP3-742</b>, demonstrating a favorable overall profile including diminished hERG inhibition and in vivo efficacy in a mouse peritonitis model.…”
  10. 1830

    Primers used in ChIP-PCR. by Lorenza Cutrone (21144285)

    Published 2025
    “…In lymphatic endothelial cells infected with KSHV and in gastric cancer cells positive for EBV, ectopic HSF2 enhances the expression of lytic genes; While knocking down HSF2 significantly decreases their expression. HSF2 overexpression is accompanied by decreased levels of repressive histone marks at the promoters of the lytic regulators KSHV ORF50 and EBV BZLF1, both characterized by poised chromatin features. …”
  11. 1831

    Primers used in RTqPCR. by Lorenza Cutrone (21144285)

    Published 2025
    “…In lymphatic endothelial cells infected with KSHV and in gastric cancer cells positive for EBV, ectopic HSF2 enhances the expression of lytic genes; While knocking down HSF2 significantly decreases their expression. HSF2 overexpression is accompanied by decreased levels of repressive histone marks at the promoters of the lytic regulators KSHV ORF50 and EBV BZLF1, both characterized by poised chromatin features. …”
  12. 1832

    All-Atom Simulations Reveal the Effect of Membrane Composition on the Signaling of the NKG2A/CD94/HLA‑E Immune Receptor Complex by Martin Ljubič (15680161)

    Published 2024
    “…These variations are particularly evident in the intracellular domain of NKG2A, manifested as changes in mobility, tyrosine exposure, and interdomain communication. Additionally, we found that a large concentration of negative charge at the surface of the POPA-based membrane greatly increased the number of contacts with lipid molecules and significantly decreased the exposure of intracellular NKG2A ITIM regions to water molecules, thus likely halting the signal transduction process. …”
  13. 1833
  14. 1834
  15. 1835

    Data used to generate Figs 2–7 and S1 Fig. by Amy J. Schuh (8520354)

    Published 2025
    “…Compared to the MARV-monoinfected bat group, the SOSV+MARV-coinfected bat group exhibited a significantly shortened duration of MARV oral shedding and a significantly decreased anti-MARV IgG response, which may increase the capacity for MARV reinfection. …”
  16. 1836

    CPSF6-NLS chimeras confer virus-specific infectivity defects. by Nicholas Rohlfes (20577485)

    Published 2025
    “…Results (mean ± SEM) are representative from 3 independent experiments with at least technical duplicate samples per experiment. …”
  17. 1837
  18. 1838
  19. 1839
  20. 1840